A new, single-center study assessed rates of adverse outcomes among patients with high-risk cutaneous squamous cell carcinoma (hrSCC) whose treatment consisted only of Moh’s micrographic surgery (MMS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results